Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Kite Can Reach Two-Week Yescarta Turn-Around Time After Manufacturing Change
Jan 30 2024
•
By
Derrick Gingery
Kite streamlined its CAR-T manufacturing to shave two days off its turn-around process. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Cell & Gene Therapies
More from Advanced Technologies